Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan...

por Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Publicado 2020

Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

por Ibrahim, Nasrien E., Piña, Ileana L., Camacho, Alexander, Bapat, Devavrat, Felker, G. Michael, Maisel, Alan S., Butler, Javed, Prescott, Margaret F., Abbas, Cheryl A., Solomon, Scott D., Januzzi, James L.
Publicado 2020

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF

por Felker, G. Michael, Butler, Javed, Ibrahim, Nasiren E., Piña, Ileana L., Maisel, Alan, Bapat, Devavrat, Camacho, Alexander, Ward, Jonathan H., Williamson, Kristin M., Solomon, Scott D., Januzzi, James L.
Publicado 2021

Racial and Ethnic Differences in the Clinical Diagnosis of Aortic Stenosis

por Crousillat, Daniela R., Amponsah, Daniel K., Camacho, Alexander, Kandanelly, Ritvik R., Bapat, Devavrat, Chen, Chen, Selberg, Alexandra, Shaqdan, Ayman, Tanguturi, Varsha K., Picard, Michael H., Hung, Judy W., Elmariah, Sammy
Publicado 2022